The Vanguard Group, Inc. recently announced the acquisition of new stake in Las Vegas Sands Corp (NYSE:LVS). The institutional investor has increased its shareholding in the Consumer Cyclical company by 0.32% to 31.28 million shares with purchase of 0.1 million shares. This fresh investment now brings its stake to 4.15% valued currently at $1.54 billion. In addition, BlackRock Fund Advisors raised its holdings by 0.14 million to 14.5 million shares. And Fisher Asset Management LLC has lifted its position by 10.76% or 1.03 million shares – to 10.59 million shares.
Currently, there are 764.25M common shares owned by the public and among those 408.40M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 18 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 14 of these insider trades were purchases, accounting for 4,059,568 shares. Insider sales of the common stock occurred on 4 occasions, with total insider shares sold totaling 5,237,216 shares.
The top 3 mutual fund holders in Las Vegas Sands Corp are Vanguard Total Stock Market ETF, Vanguard 500 Index Fund, and T Rowe Price Growth Stock Fund. Vanguard Total Stock Market ETF owns 11.99 million shares of the company’s stock, all valued at over $590.1 million. The company bought an additional 10352.0 shares recently to bring their total holdings to about 1.59% of the shares outstanding. Vanguard 500 Index Fund bought 18769.0 shares to see its total holdings expand to 9.01 million shares valued at over $443.48 million and representing 1.20% of the shares outstanding. T Rowe Price Growth Stock Fund bought 0.91 million shares to bring its total holdings to over 5.25 million shares at a value of $258.36 million. T Rowe Price Growth Stock Fund now owns shares totaling to 0.70% of the shares outstanding.
The company’s stock has a 5-day price change of -3.39% and 4.47% over the past three months. LVS shares are trading -2.60% year to date (YTD), with the 12-month market performance down to -11.84% lower. It has a 12-month low price of $43.77 and touched a high of $65.58 over the same period. LVS has an average intraday trading volume of 5.31 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.20%, -1.07%, and -9.92% respectively.
Institutional ownership of Las Vegas Sands Corp (NYSE: LVS) shares accounts for 40.28% of the company’s 764.25M shares outstanding. Mutual fund holders own 17.20%, while other institutional holders and individual stakeholders account for 23.44% and 114.04% respectively.
It has a market capitalization of $36.11B and a beta (3y monthly) value of 1.16. The stock’s trailing 12-month PE ratio is 54.46, while the earnings-per-share (ttm) stands at $0.88. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.00% over the week and 2.23% over the month.
Analysts forecast that Las Vegas Sands Corp (LVS) will achieve an EPS of $Las Vegas Sands Corp. for the current quarter, $47.93 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Novartis AG while analysts give the company a high EPS estimate of $Versus Systems Inc.. Comparatively, EPS for the current quarter was $LiveOne, Inc. a year ago. Earnings per share for the fiscal year are expected to increase by 264.08%, and 50.22% over the next financial year.
Looking at the support for the LVS, a number of firms have released research notes about the stock. Susquehanna stated their Positive rating for the stock in a research note on December 15, 2023, with the firm’s price target at $59.
